New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting?
ÌÇÐÄ´«Ã½
Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting? Journal of cardiac failure Jabagi, H., Ruel, M., Sun, L. Y. 2020; 26 (9): 776-780Abstract
Since the introduction of biomarkers in the late 1980s, considerable ÌÇÐÄ´«Ã½ has been dedicated to their validation and application. As a result, many biomarkers are now commonly used in clinical practice. However, the role of biomarkers in the prediction of right ventricular failure (RVF) and in the prognostication for patients with RVF remains underexplored. Barriers include a lack of awareness of the importance of right ventricular function, especially in the perioperative setting, as well as a lack of reproducible means to assess right ventricular function in this setting. We provide an overview of biomarkers with right ventricular prognostic capabilities that could be further explored in patients expecting cardiac surgery, who are notoriously susceptible to developing RVF. We discuss biomarkers' mechanistic pathways and highlight their potential strengths and weaknesses in use in ÌÇÐÄ´«Ã½ and clinical care.
View details for
View details for